Scientific work

Uzm. Dr. Abdussamet Çelebi

63 publications. The source of the information is stated next to each publication.

Back to profile

  1. Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors

    Journal of Immunotherapy, 2026

    DOI 10.1097/cji.0000000000000604 PMID 41972337 Source: OpenAlex

  2. Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16868-5 Open-access full textSource: OpenAlex

  3. Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study

    Journal of Immunotherapy, 2026

    DOI 10.1097/cji.0000000000000610 PMID 42267536 Source: OpenAlex

  4. Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study

    Journal of Neuro-Oncology, 2026

    DOI 10.1007/s11060-025-05415-0 PMID 41492105 Source: OpenAlex

  5. Adult-Onset Diffuse Midline Glioma, H3K27-Altered: A Genomics-Guided, Individualized, Multimodal Treatment Approach

    Brain Sciences, 2026

    DOI 10.3390/brainsci16010097 PMID 41594818 Open-access full textSource: ORCID

  6. Kanser Hastalarının Bakım Verenlerinin Bakım Yükü: Manevi İyilik Hali, Psikolojik Esneklik, Depresyon ve Anksiyete Arasındaki İlişki-Ön Bulgular

    Turkish Journal of Psychiatry, 2026

    DOI 10.5080/61upk.ozt269 Open-access full textSource: OpenAlex

  7. Acquired CD74–ROS1 fusion–mediated osimertinib resistance successfully treated with osimertinib and crizotinib: a case report

    Journal of Chemotherapy, 2026

    DOI 10.1080/1120009x.2026.2657116 PMID 41992733 2 citations (OpenAlex) Source: OpenAlex

  8. Digital health engagement and health literacy among cancer patients: a cross-sectional study of ICT usage patterns

    BMC Health Services Research, 2026

    DOI 10.1186/s12913-026-15432-y 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  9. Oncological Perspective on Bone-Metastatic Colorectal Cancer: a Single-Centre Experience

    Journal of Gastrointestinal Cancer, 2026

    DOI 10.1007/s12029-026-01457-3 PMID 41944932 Source: OpenAlex

  10. Comparative overall survival in T4N0 and T2-3N1 non-metastatic colon cancer: a retrospective cohort study

    Annals of Saudi Medicine, 2026

    DOI 10.5144/0256-4947.2026.169 PMID 42251515 Open-access full textSource: OpenAlex

  11. Baseline and Early On-Treatment Prognostic Nutritional Index in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15176790 PMID 42739793 Open-access full textSource: OpenAlex

  12. Prognostic Value of a Seven-Factor Risk Stratification System in T3N0 Colon Cancer: A Single-Center Retrospective Study

    Medicina, 2026

    DOI 10.3390/medicina62101846 PMID 42942377 Open-access full textSource: OpenAlex

  13. Healthy Lifestyle Behaviors and Health Literacy in Oncology Patients: Evaluation of Organic Food Consumption and Physical Activity

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.269303 Source: OpenAlex

  14. Temporal Changes in Age at Diagnosis of Colorectal Cancer in Turkiye: A 9-Year Single-Center Analysis

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.2612638 Source: OpenAlex

  15. Kidney Metastasis of Small Cell Lung Cancer Under Immunotherapy: Case Report

    Bulletin of Urooncology, 2026

    DOI 10.4274/uob.galenos.2025.2025.2.5 Open-access full textSource: OpenAlex

  16. Bone marrow metastasis in prostate cancer: Treatment feasibility and survival in a real-world cohort.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e17051 Open-access full textSource: OpenAlex

  17. Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14062024 PMID 40142832 16 citations (Europe PMC) Open-access full textSource: OpenAlex

  18. Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis

    Nigerian Journal of Clinical Practice, 2025

    DOI 10.4103/njcp.njcp_848_23 PMID 40326903 Open-access full textSource: OpenAlex

  19. Kanserde Takip

    Akademisyen Kitabevi eBooks, 2025

    DOI 10.37609/akya.3716 Open-access full textSource: OpenAlex

  20. Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14041071 PMID 40004601 9 citations (Europe PMC) Open-access full textSource: OpenAlex

  21. Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey

    Journal of Chemotherapy, 2025

    DOI 10.1080/1120009x.2024.2430845 PMID 39588941 1 citation (Europe PMC) Source: ORCID

  22. The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy

    Medicina, 2025

    DOI 10.3390/medicina61081449 PMID 40870493 1 citation (Europe PMC) Open-access full textSource: ORCID

  23. Effects of neoadjuvant and adjuvant chemotherapy on survival in muscle-invasive bladder cancer: A multicenter study

    Turkish Journal of Clinics and Laboratory, 2025

    DOI 10.18663/tjcl.1575691 Open-access full textSource: ORCID

  24. Oncological perspective on Kaposi sarcoma: A single-centre experience

    Marmara Medical Journal, 2025

    DOI 10.5472/marumj.1627569 Open-access full textSource: ORCID

  25. The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis

    Medicina, 2025

    DOI 10.3390/medicina61010144 PMID 39859125 1 citation (Europe PMC) Open-access full textSource: ORCID

  26. Clinical and Demographic Features in Malignant Peritoneal Mesothelioma: Treatment Approaches and Factors Affecting Survival

    Journal of Oncological Sciences, 2025

    DOI 10.37047/jos.galenos.2025.2025-3-18 Open-access full textSource: OpenAlex

  27. Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study

    Annals of Saudi Medicine, 2025

    DOI 10.5144/0256-4947.2025.249 PMID 40753462 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  28. Prognostic Nutritional Index as a Biomarker in Metastatic Hormone-Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization

    The Prostate, 2025

    DOI 10.1002/pros.24876 PMID 39972650 8 citations (Europe PMC) Open-access full textSource: Europe PMC

  29. Clinical Outcomes of CDK4/6 Inhibitor Therapy in HR+/HER2− Metastatic Breast Cancer: A Multicenter Comparison of HER2‐Low and HER2‐Zero Subgroups

    The Breast Journal, 2025

    DOI 10.1155/tbj/5577345 PMID 40620732 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  30. Impact of Sarcopenia and Osteopenia on Prognosis in Metastatic Biliary Tract Cancer: A Single Center Experience

    Nutrition and Cancer, 2025

    DOI 10.1080/01635581.2025.2496371 PMID 40327413 1 citation (OpenAlex) Source: OpenAlex

  31. Does toxicity of cyclin-dependent kinase 4/6 inhibitor predict treatment response in metastatic hormone-positive breast cancer patients?

    Oncology in Clinical Practice, 2025

    DOI 10.5603/ocp.101970 Open-access full textSource: OpenAlex

  32. Colorectal Cancer Metastasizing to the Thyroid Gland: A Rare and Interesting Case

    Journal of Oncological Sciences, 2025

    DOI 10.37047/jos.galenos.2025.2025-3-11 Open-access full textSource: OpenAlex

  33. Tiroit ve Paratiroit Tümörleri

    Akademisyen Kitabevi eBooks, 2025

    DOI 10.37609/akya.3716.c6089 Source: ORCID

  34. Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer.

    PubMed Central, 2025

    DOI 10.5144/0256-4947.2025.18 PMID 39929787 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  35. Sex-related disparities in outcomes of survival in biliary tract cancer patients

    Journal of Cancer Research and Clinical Oncology, 2025

    DOI 10.1007/s00432-025-06096-y PMID 40016575 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  36. Denovo Metastatic Primary Gastric Ewing Sarcoma/Primitive Neuroectodermal Tumor– 13 Years Follow-up: Case Report and Review of Literature

    Journal of Medicine and Medical Studies, 2025

    DOI 10.51219/jmms/guren-ak/19 Open-access full textSource: OpenAlex

  37. Prognostic implications of cancer-associated fibroblasts and desmoplastic reaction in stage III colon cancer risk groups

    Future Oncology, 2025

    DOI 10.1080/14796694.2025.2567845 PMID 41047636 Open-access full textSource: OpenAlex

  38. The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study

    International Journal of Clinical Oncology, 2024

    DOI 10.1007/s10147-023-02460-5 PMID 38310597 6 citations (Europe PMC) Source: OpenAlex

  39. 71P The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: A Turkish Oncology Group (TOG) study

    ESMO Open, 2024

    DOI 10.1016/j.esmoop.2024.102300 Open-access full textSource: OpenAlex

  40. Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-56046-w PMID 38461209 16 citations (Europe PMC) Open-access full textSource: OpenAlex

  41. Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380 Open-access full textSource: OpenAlex

  42. Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience

    Oncology Research and Treatment, 2024

    DOI 10.1159/000537988 PMID 38565096 2 citations (Europe PMC) Open-access full textSource: ORCID

  43. Prognostic value of systemic inflammatory markers in renal cell carcinoma with isolated lung metastases: A retrospective analysis

    Turkish Journal of Clinics and Laboratory, 2024

    DOI 10.18663/tjcl.1531223 Open-access full textSource: ORCID

  44. Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study

    Biomolecules and Biomedicine, 2024

    DOI 10.17305/bb.2024.10512 PMID 38920621 1 citation (Europe PMC) Open-access full textSource: ORCID

  45. HER2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: A case report

    Anti-Cancer Drugs, 2024

    DOI 10.1097/cad.0000000000001625 PMID 39115060 4 citations (Europe PMC) Source: ORCID

  46. Systemic Inflammation Response Index and Pan-Immune-Inflammation Value: Prognostic Significance in Metastatic Melanoma

    Journal of Oncological Science, 2024

    DOI 10.37047/jos.2024-105164 Open-access full textSource: ORCID

  47. Ekinezya (Echinacea Purpurea)

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2380.c13885 Source: ORCID

  48. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 citations (Europe PMC) Open-access full textSource: OpenAlex

  49. Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens

    Oncology Letters, 2023

    DOI 10.3892/ol.2023.13795 PMID 37123028 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  50. PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score

    Journal of Clinical Medicine, 2023

    DOI 10.3390/jcm12196420 PMID 37835062 3 citations (Europe PMC) Open-access full textSource: OpenAlex